Orchestra BioMed receives Breakthrough Device Designation for its hypertension therapy
April 22nd 2025The company received the designation for its atrioventricular interval modulation therapy, a novel pacemaker-based treatment aimed at reducing blood pressure in patients with uncontrolled hypertension and elevated cardiovascular risk.